Neeraj Sinha

Neeraj Sinha

Auto-generated profile, based on publicly available information

Neeraj Sinha

Lung Transplantation Program, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA, jefferson.edu

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2020 in Postgraduate Medical Journal
Verified
Journal Article
Open access
PDF file
NSNeeraj Sinha
Neeraj Sinha
GBGalit Balayla
Galit Balayla
Hydroxychloroquine and chloroquine are medications that have been used for a long time. Their most common use is for the treatment and prophylaxis of malaria. However, these antimalarial drugs are known to also have anti-inflammatory and antiviral effects and are used for several chronic diseases such as systemic lupus erythematosus with low adverse effects. The antiviral action of hydroxychloroquine and chloroquine has been a point of interest to different researchers due to its mechanism of action. Several in vitro studies have proven their effectiveness on severe acute respiratory syndrome virus and currently both in vitro and in vivo studies have been conducted on 2019 novel coronavirus (covid-19). The purpose of this article is to review the history and mechanism of actions of these drugs and the potential use they can have on the current covid-19 pandemic.

12 August 2022 in Transplant Infectious Disease
Verified
Journal Article
Open access
SAShweta Anjan
Shweta Anjan
AKAkshay Khatri
Akshay Khatri
JVJulia Bini Viotti
Julia Bini Viotti
TCTeresa Cheung
Teresa Cheung
LGLeopoldo A. Cordova Garcia
Leopoldo A. Cordova Garcia
YNYoichiro Natori
Yoichiro Natori
Solid organ transplant (SOT) recipients are at high risk for severe disease with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Emerging variants of concern have disproportionately affected this population. Data on severity and outcomes with the Omicron variant in SOT recipients are limited. Thus we conducted this single‐center, retrospective cohort study of SOT recipients diagnosed with SARS‐CoV‐2 infection from December 18, 2021 to January 18, 2022, when prevalence of the Omicron variant was more than 80%‐95% in the community. Univariate and multivariate logistic regression analysis was performed to identify risk factors for hospital admission. We identified 166 SOT patients: 112 (67.5%) kidney, 22 (13.3%) liver, 10 (6.0%) lung, seven (4.2%) heart, and 15 (9.0%) combined transplants. SARS‐CoV‐2 vaccine series was completed in 59 (35.5%) recipients. Ninety‐nine (59.6%) and 13 (7.8%) recipients received casirivimab/imdevimab and sotrovimab, respectively. Fifty‐three (32%) recipients required hospital admission, of which 19 (35.8%) required intensive care unit level of care. Median follow‐up was 50 (interquartile range, 25‐59) days, with mortality reported in six (3.6%) patients. Risk factors identified for hospital admission were African American race (p < .001, odds ratio [OR] 4.00, 95% confidence interval [CI] 1.84‐8.70), history of coronary artery disease (p = .031, OR 3.50, 95% CI 1.12‐10.87), and maintenance immunosuppression with corticosteroids (p = .048, OR 2.00, 95% CI 1.01‐4.00). In conclusion, contrary to that in the general population, we found a higher hospital admission rate in SOT recipients with omicron variant infection. Further studies to investigate the efficacy of newer treatments are necessary, even as outcomes continue to improve. image

2 March 2021 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
NSNeeraj Sinha
Neeraj Sinha
AGAhmad Goodarzi
Ahmad Goodarzi
RARadhika Akku
Radhika Akku
GBGalit Balayla
Galit Balayla

17 September 2020 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
NSNeeraj Sinha
Neeraj Sinha
GBGalit Balayla
Galit Balayla
JBJoao Braghiroli
Joao Braghiroli

1 June 2023 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
YNYoichiro Natori
Yoichiro Natori
SAShweta Anjan
Shweta Anjan
JSJacques Simkins
Jacques Simkins
LALilian Abbo
Lilian Abbo
SMSuresh Manickavel
Suresh Manickavel
TMTiago Machuca
Tiago Machuca

1 October 2015 in Chest
Verified
Journal Article
Open access
JTJoseph Thachuthara-George
Joseph Thachuthara-George
SNSinha Neeraj
Sinha Neeraj
BBBrian Buckner
Brian Buckner
BMBabith Mankidy
Babith Mankidy
SSScott Scheinin
Scott Scheinin
TKThomas Kaleekal
Thomas Kaleekal